Kaiser Health News: Drugmakers Play The Patent Game To Lock In Prices, Block Competitors
October 03, 2018
FDA Commissioner Scott Gottlieb calls “patent thickets,” claiming multiple patents for a single drug to build protection from competitors...
Drug Benefit Solutions is an educational platform explaining how pharmacy benefit managers (PBMs) reduce costs and improve quality on prescription drug benefits for consumers, employers, unions, and government programs.
Drug Benefit Solutions is a project of the Pharmaceutical Care Management Association (PCMA).
Recent News
Filter by:
Highlights
Filter by Year:Clear Filters- Highlights
- Biosimilars
- Drug Abuse Prevention
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Formulary Design
- Fraud
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- Specialty Pharmacies
- TRICARE
- Waste
Forbes: Abolishing Drug Rebates May Push Consumer Drug Costs Higher
September 27, 2018
In fact, there is considerable evidence that rebates help reduce drug costs...
The Wall Street Journal: Drug Rebates Aren’t ‘Kickbacks’
September 17, 2018
Consumers also benefit directly from rebates paid to PBMs...
The Weekly Standard: A Great Way to Increase Drug Costs Even More
September 17, 2018
Rebates are the mechanism through which insurers and PBMs achieve discounts from the “list” price for drugs....
STAT News: Rush to end drug rebates may be bad for patients, payers, and pharma
September 07, 2018
Rebates for drugs have worked for decades to provide a mechanism for health plans and their clients to negotiate drug...
The Washington Post: Rebates aren’t the problem. Drug companies’ prices are
September 04, 2018
The president has made it very clear he wants the same thing Americans want: for drug companies to lower their...
August 22, 2018
“The administration understands … PBMs are part of the solution,” Merritt said....
Townhall: Pharma Is Running Out of Scapegoats for High Drug Prices
August 17, 2018
When it comes to their prices, Pharma has no good defense, so they’ve been forced to rely on an endless...
The Washington Examiner: Drug middlemen push back that rebates are to blame for high drug prices
August 15, 2018
Drug companies are launching new products at higher list prices, regardless of whether they get a rebate....
Politico: PBMs Hit Back Over Drug Pricing Drivers
August 15, 2018
“Simply eliminating plans’ ability to negotiate price concessions would enrich drugmakers at the expense of patients, who’d not only face...
Healthcare Dive: CMS to allow step therapy in MA plans in bid to boost price competition
August 08, 2018
Dan Best, CMS senior advisor for drug pricing reform, told reporters the policy could save 15-20% of the $12 billion...
CNBC: Trump administration opens up more drugs covered by Medicare to price negotiations
August 08, 2018
Today’s announcement by the Administration to include greater use of PBM tools in Medicare Part B through Medicare Advantage Prescription...